Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination–Related Genes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes
J. Clin. Oncol 2020 Oct 29;[EPub Ahead of Print], NM Tung, ME Robson, S Ventz, CA Santa-Maria, R Nanda, PK Marcom, PD Shah, TJ Ballinger, ES Yang, S Vinayak, M Melisko, A Brufsky, M DeMeo, C Jenkins, S Domchek, A D'Andrea, NU Lin, ME Hughes, LA Carey, N Wagle, GM Wulf, IE Krop, AC Wolff, EP Winer, JE GarberFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.